There is significant evidence that opioids are not the right treatment of choice for migraine in the emergency department.
The results highlight the importance of evaluating and monitoring cognitive function in individuals with recent critical illness or major infections, especially if they are already at risk for dementia.
The new guidelines will facilitate the design and development of clinical trials to test new therapies to minimize the burden of neurologic disability produced by neurosarcoidosis.
There are considerations for treating these seizures as part of the overall goals of palliative care, which include the family’s experience.
Future studies on VR training for MS should include large randomized controlled trials using clear protocols and comparable between-group tasks.
Companies touting these therapies may use impressive websites with endorsements by celebrities and physicians to instill a sense that the procedures are safe and acceptable.
Data in children do support an association between pediatric obesity and headache disorders in general, but more research is needed to confirm the association specifically with pediatric migraine.
While it is now well-established that having MS should not limit patients’ reproductive choices, this was not always the case.
Direct-to-consumer genetic testing would enable consumers to bypass the safeguards set forth by professional guidelines, which could potentially increase the risk for harm associated with testing.